Logo

    fluoroquinolones

    Explore " fluoroquinolones" with insightful episodes like "Carbapenem-Resistant Acinetobacter baumannii: Applying Best Practices in Complex Clinical Scenarios", "Best Practices in Managing Uncomplicated UTIs in the Emergency Department", "Updates in Antimicrobial Selection for uUTIs" and "D-dimer Adjusted for Clinical Probability of PE, Work Schedules of Hospitalists, Inappropriate Fluoroquinolone Prescribing, Utilization and Outcomes of Lytics in Acute PE" from podcasts like ""CCO Infectious Disease Podcast", "CCO Infectious Disease Podcast", "CCO Infectious Disease Podcast" and "Last Week in Medicine"" and more!

    Episodes (4)

    Carbapenem-Resistant Acinetobacter baumannii: Applying Best Practices in Complex Clinical Scenarios

    Carbapenem-Resistant Acinetobacter baumannii: Applying Best Practices in Complex Clinical Scenarios

    In this episode, Emily Heil, PharmD, MS, BCIDP, AAHIVP; Laila Woc-Colburn, MD; and Trevor Van Schooneveld, MD, FSHEA, FACP, discuss their approach to managing infections involving carbapenem-resistant Acinetobacter baumannii (CRAB), including: 

    • Mechanisms for β-lactam resistance
    • Additional resistance mechanisms and virulence factors
    • 2023 IDSA guidance recommendations for moderate to severe CRAB infections
    • The latest clinical data by antimicrobial therapy/regimen:
    • Sulbactam
    • Meropenem and colistin
    • Carbapenem, sulbactam, and polymyxin B
    • Tetracyclines
    • Cefiderocol
    • Sulbactam/durlobactam and carbapenems
       

    Program Director:

    Trevor Van Schooneveld, MD, FSHEA, FACP 
    Professor, Division of Infectious Diseases
    Program Director, Infectious Diseases Fellowship
    Medical Director, Antimicrobial Stewardship Program
    University of Nebraska Medical Center
    Omaha, Nebraska

    Faculty:

    Emily Heil, PharmD, MS, BCIDP, AAHIVP
    Associate Professor
    Department of Pharmacy
    University of Maryland 
    School of Pharmacy
    ID Clinical Pharmacy Specialist
    University of Maryland Medical Center
    Baltimore, Maryland

    Laila Woc-Colburn, MD
    Associate Professor
    Division of Infectious Diseases
    Emory University School of Medicine 
    Atlanta, Georgia

    Content based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.

    Follow along with a downloadable slideset at: 
    https://bit.ly/476v2wI

    Link to full program: 
    https://bit.ly/40Mmicz

    Best Practices in Managing Uncomplicated UTIs in the Emergency Department

    Best Practices in Managing Uncomplicated UTIs in the Emergency Department

    In this episode, Lilly C. Lee, MD, SM, FACEP, FAAEM, discusses the best practices in management of uUTI in the emergency department, including:

    • Patient triage
    • Diagnostic stewardship
    • Interdisciplinary care
    • Strategies to overcome treatment barriers

    Presenter:

    Lilly C. Lee, MD, SM, FACEP, FAAEM
    Chief of Emergency Medicine
    Jackson Memorial Hospital
    Florida Poison Information Center
    Roxcy Bolton Rape Treatment Center
    Affiliated Assistant Professor of Surgery
    DeWitt Daughtry Family Department of Surgery
    Leonard M. Miller School of Medicine
    University of Miami
    Miami, Florida

    Find other program activities here: 

     

    Updates in Antimicrobial Selection for uUTIs

    Updates in Antimicrobial Selection for uUTIs

    In this episode, Lillian Abbo, MD, MBA, FIDSA, discusses appropriate antimicrobial selection for managing uncomplicated UTIs, including:

    • Balancing discrepancies in available guidelines 
    • Individualizing antimicrobial selection based on patient characteristics and local resistance patterns 
    • Incorporating tools, like antibiograms, into daily practice 
    • Being a good steward of currently available antimicrobial agents 
    • Planning ahead for emerging therapies for uncomplicated UTIs

    Presenter:

    Lillian Abbo, MD, MBA, FIDSA
    Associate Chief Medical Officer 
    Infectious Diseases
    Jackson Health System
    Professor of Clinical Infectious Diseases
    University of Miami Miller School of Medicine
    Miami Transplant Institute
    Miami, Florida

    Find other program activities here: 

    D-dimer Adjusted for Clinical Probability of PE, Work Schedules of Hospitalists, Inappropriate Fluoroquinolone Prescribing, Utilization and Outcomes of Lytics in Acute PE

    D-dimer Adjusted for Clinical Probability of PE, Work Schedules of Hospitalists, Inappropriate Fluoroquinolone Prescribing, Utilization and Outcomes of Lytics in Acute PE

    Can you get away with a higher d-dimer value in patients with a low pre-test probability for PE?  Does working more days in a row improve patient outcomes?  How often are people inappropriately prescribing fluoroquinolones?  How often are people using systemic lytics vs catheter directed lytics in acute PE, and what are the outcomes?


    Music from https://filmmusic.io
    "Sneaky Snitch" by Kevin MacLeod (https://incompetech.com)
    License: CC BY (http://creativecommons.org/licenses/by/4.0/)